Article Details
Retrieved on: 2021-07-12 06:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“We will continue to invest in oncology, neuroscience, gastric science, and kidney science to improve our margins,” said Rajagopal. At SRL, he added, ...
Article found on: californianewstimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here